Login
| TI Ref No : | 527834348 |
|---|---|
| Description : | Market Research To Determine The Purchase Price Of Enfortumab Vedotin At A Dose Of 20 Mg (11,500 Doses) And 30 Mg (7,670 Doses) And Pembrolizumab At A Dose Of 100 Mg (2,550 Doses) For The Purposes Of The Medical Research Agencys Own Study |
| Date : | 2026-01-22 |
| Deadline : | 2026-02-04 |
| Document Type : | Tenders |
